company tower banner
HTBA (HealthTech BioActives, S.L.U.) Company Logo
Cardiose is a patented ingredient derived from citrus, offering benefits for heart health and sports performance. It maintains arterial flexibility and minimizes cardiovascular risk factors while also improving physical performance and extending endurance. Cardiose is GRAS-approved for use in supplements and food, making it a safe and reliable option. Its target markets include Food and Nutrition, where it serves as a valuable addition to promote heart health and enhance athletic performance.

Labeling Claims: Allergen-free, Gluten-free, Halal, Kosher, Natural, Non-GMO

Certifications & Compliance: ECOVADIS, FAMI-QS, FSSC 22000, GMP, Generally Recognized As Safe (GRAS), Halal, Hazard Analysis Critical Control Point (HACCP), ISO 14001, ISO 9001, Kosher

Benefit Claims (Health): Cardioprotective, Controls Diastolic Blood Pressure, Decreases LDL Cholesterol, Improves Blood Circulation, Improves Endurance, Improves FMD(Flow-Mediated Dilation), Increases HDL Cholesterol, Supports Cardiovascular health

Features: Reduction in Cholesterol, Superior Performance

Knowde Enhanced TDS

Identification & Functionality

Active Component
Food Ingredients Functions
Pharma & Nutraceuticals Functions

Features & Benefits

Product Benefits
  • Patented ingredient from citrus with benefits for heart health and sports performance.
  • Improves physical performance and extends endurance.
  • Maintains arterial flexibility and minimizes cardiovascular risk factors.
Cardiose maintains Arterial Flexibility

Flow Mediated Dilation (FMD)
Flow-mediated dilation (FMD) is an accepted technique to quantify endothelial function, showing a predictive value for cardiovascular disease. To measure FMD, shear stress is induced by occluding the upper-arm for five minutes, followed by cuff release. Changes in blood flow cause an endothelial response that is assessed measuring artery diameter with ultrasound.

Cardiose’s led to a significant improvement in FMD:

  • In individuals with metabolic syndrome after supplementation of 500 mg/day Cardiose® for three weeks.

Cardiose - Cardiose Maintains Arterial Flexibility

  • After the intake of a high-fat meal in overweight individuals supplemented with Cardiose® (500 mg/day) for a period of six weeks.

Cardiose® also reduces the levels of systemic inflammation markers.

Cardiose - Cardiose Maintains Arterial Flexibility - 1


Laser Doppler Flowmetry and Iontophoresis

Laser Doppler Flowmetry uses laser light to measure red blood cell velocity and concentration, and therefore, to evaluate blood flux in microvasculature. The endothelium function in these micro-vessels is assessed by administering vasodilator agonists through the skin using small electrical currents (iontophoresis).

Cardiose® consumption causes a significant improvement in microvascular reactivity

In healthy, moderately overweight men, after acute consumption. The increase in blood flow was significantly correlated with the concentrations of hesperidin metabolites in blood plasma.

Cardiose reduces Plaque Formation

Endothelial adhesion molecules are key components for the normal function of the cardiovascular system.

However, endothelial adhesion molecules like E-selectin, VCAM-1 and ICAM-1 are potent adhesion molecules that trigger platelets and white blood cells to stick to arterial walls.

Elevated serum concentrations of these cell adhesion molecules are related to cardiovascular disease (CVD)11. High levels of these molecules induce thrombus formation, and promote plaque formation, leading to atherosclerosis.

Cardiose® may modulate the altered concentration of these molecules:

Cardiose - Cardiose Reduces Plaque Formation


Adhesion molecule reduction following supplementation

After four weeks of Cardiose® consumption (600 mg/day) E-selectin concentration decreased in patients suffering from myocardial infarction. In the same way, the three-week
Cardiose® supplementation (500 mg/day) led to a reduction of the circulating concentrations of soluble E-Selectin in individuals with Metabolic Syndrome.

Six weeks of Cardiose® supplementation brought about a significant down-regulation of circulating soluble VCAM-1 and ICAM-1 molecules in an overweight population.

Applications & Uses

Food & Nutrition Applications

Properties

Physical Form
Appearance
Light brown to yellowish powder
Odor
Characteristic
Insoluble in
Water
Slightly Soluble in
Alcohol
Soluble in
Diluted alkali
Microbiological Values
ValueUnitsTest Method / Conditions
Total Plate Countmax. 10°cfu/g
Total Yeast and Molds Countmax. 10cfu/g
SalmonellaAbsence/25g
Escherichia coliAbsence/g
Assay
ValueUnitsTest Method / Conditions
Rutinoside (on anhydrous basis)min. 90%HPLC
Specifications
ValueUnitsTest Method / Conditions
Loss on dryingmax. 5%
Sulphated ashmax. 0.2%
Lead Contentmax. 0.5ppm
Cadmium Contentmax. 1ppm
Mercurymax. 0.1ppm
Arsenic Contentmax. 0.2ppm
S Isomermin. 85%

Regulatory & Compliance

Technical Details & Test Data

Identification

A. Infrared absorption spectrophotometry. Comparison: Working standard.
B. Examine the chromatograms obtained in the assay.
Results: the principal peak in the chromatogram obtained with the test solution is similar in retention time and size to the principal peak in the chromatogram obtained with working standard solution.

Cardiose Heart Health from the Mediterranean

Standard hesperidin consists of a mixture of S-and R-isomers. In nature the 2S-hesperidin is dominant.
Cardiose® has an S:R ratio that is closer to the natural form.

Better bioavailability
Cardiose - Cardiose Heart Health From The Mediterranean

 

Distinctive positioning

Cardiose - Cardiose Heart Health From The Mediterranean - 1

 

Cardiose minimizes Cardiovascular Risk Factors

Elevated levels of cholesterol and fats put us at risk of experiencing serious cardiovascular events.

Impact on cholesterol levels

  • A three week treatment with Cardiose® (500 mg/day) in individuals with Metabolic Syndrome caused a significant:
    • ↓ Total cholesterol.
    • ↑ High-density lipoprotein (HDL).
    • ↑  Apolipoprotein B, the main proteic component of LDL.
  • Supplementation with Cardiose® (600 mg/day) in post-infarction subjects significantly increased HDL levels and decreased LDL levels.

Cardiose - Cardiose Minimizes Cardiovascular Risk Factors


High blood pressure values are considered a major risk factor for cardiovascular diseases. The development of CVD can be prevented by lowering one’s blood pressure.

Impact on blood pressure

  • A four-week consumption of Cardiose® significantly lowered diastolic, but not systolic, blood pressure in moderately overweight healthy men.
  • Similarly, a trend towards lower systolic and diastolic blood pressure was also observed after six weeks of Cardiose® supplementation in overweight individuals.


Cardiose - Cardiose Minimizes Cardiovascular Risk Factors - 1